Cargando…
IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein
BACKGROUND: Cytokines and macrophages play a central role in the development of atherosclerosis. Interleukin (IL)-17 is a pro-inflammatory cytokine with differential effects on innate immune cells. We investigated the effects of IL-17 on macrophage differentiation and foam cell formation and activat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634956/ https://www.ncbi.nlm.nih.gov/pubmed/29017604 http://dx.doi.org/10.1186/s12944-017-0588-1 |
_version_ | 1783270187544346624 |
---|---|
author | de la Paz Sánchez-Martínez, María Blanco-Favela, Francisco Mora-Ruiz, Mónica Daniela Chávez-Rueda, Adriana Karina Bernabe-García, Mariela Chávez-Sánchez, Luis |
author_facet | de la Paz Sánchez-Martínez, María Blanco-Favela, Francisco Mora-Ruiz, Mónica Daniela Chávez-Rueda, Adriana Karina Bernabe-García, Mariela Chávez-Sánchez, Luis |
author_sort | de la Paz Sánchez-Martínez, María |
collection | PubMed |
description | BACKGROUND: Cytokines and macrophages play a central role in the development of atherosclerosis. Interleukin (IL)-17 is a pro-inflammatory cytokine with differential effects on innate immune cells. We investigated the effects of IL-17 on macrophage differentiation and foam cell formation and activation in response to oxidized low-density lipoprotein (oxLDL). METHODS: Human monocytes were treated with IL-17 to induce macrophage differentiation. As controls, human monocytes were differentiated into M1 macrophages (M1) or M2 macrophages (M2). Subsequently, we analyzed the expression levels of markers such as CD80, CD36 and Toll-like receptors (TLRs) as well as foam cell formation and cytokines in M1, M2 and macrophages differentiated with IL-17 with or without oxLDL. RESULTS: The expression of M1 or M2 markers or cytokines was not induced in macrophages differentiated with IL-17. Macrophages differentiated with IL-17 formed few foam cells, with an average proportion of 20%, and expressed 3 times as much TLR2 and 3.8 times as much TLR4 as M0 macrophages. Additionally, macrophages differentiated with IL-17 acquired inflammatory capacity in response to oxLDL through the expression of specific markers, such as CD80, which increased 18-times compared with macrophages differentiated with IL-17 alone, and secreted 1.3 times less tumor necrosis factor (TNF)-α than M1. Additionally, oxLDL increased the levels of CD80, CD86 and IL-6 by 5.7, 2.8 and 1.4 times in M1 compared with M1 in the absence of oxLDL. In M2, oxLDL induced increases in the secretion of IL-6 and TNF-α that were 1.9 times and 1.2 times smaller, respectively, than those observed in M1. CONCLUSION: Our study demonstrates that differentiation of macrophages with IL-17 does not induce the expression of markers or cytokines characteristic of M1 or M2 and these macrophages form few foam cells; however, the expression of TLR is increased. Moreover, these macrophages acquire the inflammatory capacity as evidenced by the expression of costimulatory molecules and secretion of pro-inflammatory cytokines in response to oxLDL. These findings suggest that the activation of macrophages differentiated with IL-17 by oxLDL contributes to the inflammatory process of atherosclerosis. |
format | Online Article Text |
id | pubmed-5634956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56349562017-10-19 IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein de la Paz Sánchez-Martínez, María Blanco-Favela, Francisco Mora-Ruiz, Mónica Daniela Chávez-Rueda, Adriana Karina Bernabe-García, Mariela Chávez-Sánchez, Luis Lipids Health Dis Research BACKGROUND: Cytokines and macrophages play a central role in the development of atherosclerosis. Interleukin (IL)-17 is a pro-inflammatory cytokine with differential effects on innate immune cells. We investigated the effects of IL-17 on macrophage differentiation and foam cell formation and activation in response to oxidized low-density lipoprotein (oxLDL). METHODS: Human monocytes were treated with IL-17 to induce macrophage differentiation. As controls, human monocytes were differentiated into M1 macrophages (M1) or M2 macrophages (M2). Subsequently, we analyzed the expression levels of markers such as CD80, CD36 and Toll-like receptors (TLRs) as well as foam cell formation and cytokines in M1, M2 and macrophages differentiated with IL-17 with or without oxLDL. RESULTS: The expression of M1 or M2 markers or cytokines was not induced in macrophages differentiated with IL-17. Macrophages differentiated with IL-17 formed few foam cells, with an average proportion of 20%, and expressed 3 times as much TLR2 and 3.8 times as much TLR4 as M0 macrophages. Additionally, macrophages differentiated with IL-17 acquired inflammatory capacity in response to oxLDL through the expression of specific markers, such as CD80, which increased 18-times compared with macrophages differentiated with IL-17 alone, and secreted 1.3 times less tumor necrosis factor (TNF)-α than M1. Additionally, oxLDL increased the levels of CD80, CD86 and IL-6 by 5.7, 2.8 and 1.4 times in M1 compared with M1 in the absence of oxLDL. In M2, oxLDL induced increases in the secretion of IL-6 and TNF-α that were 1.9 times and 1.2 times smaller, respectively, than those observed in M1. CONCLUSION: Our study demonstrates that differentiation of macrophages with IL-17 does not induce the expression of markers or cytokines characteristic of M1 or M2 and these macrophages form few foam cells; however, the expression of TLR is increased. Moreover, these macrophages acquire the inflammatory capacity as evidenced by the expression of costimulatory molecules and secretion of pro-inflammatory cytokines in response to oxLDL. These findings suggest that the activation of macrophages differentiated with IL-17 by oxLDL contributes to the inflammatory process of atherosclerosis. BioMed Central 2017-10-10 /pmc/articles/PMC5634956/ /pubmed/29017604 http://dx.doi.org/10.1186/s12944-017-0588-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research de la Paz Sánchez-Martínez, María Blanco-Favela, Francisco Mora-Ruiz, Mónica Daniela Chávez-Rueda, Adriana Karina Bernabe-García, Mariela Chávez-Sánchez, Luis IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title | IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title_full | IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title_fullStr | IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title_full_unstemmed | IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title_short | IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
title_sort | il-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634956/ https://www.ncbi.nlm.nih.gov/pubmed/29017604 http://dx.doi.org/10.1186/s12944-017-0588-1 |
work_keys_str_mv | AT delapazsanchezmartinezmaria il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein AT blancofavelafrancisco il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein AT moraruizmonicadaniela il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein AT chavezruedaadrianakarina il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein AT bernabegarciamariela il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein AT chavezsanchezluis il17differentiatedmacrophagessecreteproinflammatorycytokinesinresponsetooxidizedlowdensitylipoprotein |